Senior Researcher in Health Economics
My research interests relate to economic issues associated with the increasing availability of genetic data, including how these data might be used to support causal inference and prognostic modelling in relation to health and socioeconomic outcomes. I recently (2020) completed a three-year MRC Skills Development Fellowship using Mendelian Randomization to study the causal effect of traits, behaviours and health conditions on healthcare costs and on quality of life.
In addition to my role in the Department, I am also a Junior Research Fellow in Social Sciences in the Centre for Personalised Medicine at St Anne’s College.
I hold degrees in Economics from Trinity College Dublin (BA) and Nuffield College, Oxford (MPhil and DPhil), and in Health Economics from the University of York (MSc). I hold a diploma in Financial Management awarded by the ACCA.
Before joining the Department, I held my fellowship at the MRC Integrative Epidemiology Unit at the University of Bristol. I also worked for a number of years as an economic consultant in the private sector, advising regulators, governments and large corporates on the economic issues that arise in the regulation of network industries.
Long term cost effectiveness of interventions for obesity: A Mendelian randomization study
Dixon P. et al, (2021), PLoS Medicine
Protocol for an 'efficient design' cluster randomised controlled trial to evaluate a complex intervention to improve antibiotic prescribing for CHIldren presenting to primary care with acute COugh and respiratory tract infection: The CHICO study
Seume P. et al, (2021), BMJ Open, 11
Observational Cost-Effectiveness Analysis Using Routine Data: Admission and Discharge Care Bundles for Patients with Chronic Obstructive Pulmonary Disease
Dixon P. et al, (2020), PharmacoEconomics - Open, 4, 657 - 667
The causal effects of health conditions and risk factors on social and socioeconomic outcomes: Mendelian randomization in UK Biobank.
Harrison S. et al, (2020), Int J Epidemiol, 49, 1661 - 1681
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
Hollingworth W. et al, (2020), PharmacoEconomics - Open, 4, 427 - 438